Coherus BioSciences | 8-K: Current report
Coherus BioSciences | 8-K: Current report
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Karachun Rita A
Coherus BioSciences | 3: Initial statement of beneficial ownership of securities-Director Karachun Rita A
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Erbez Georgia
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Newton Charles W.
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Ryan Michael Lee
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Wahlstrom Mats
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director STOLPER MARK
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Newcomer Lee Nisley
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director TZOUMAKAS KIMBERLY JO
Coherus BioSciences | 4: Statement of changes in beneficial ownership of securities-Director O'Donnell-Tormey Jill
Coherus BioSciences | 8-K: Current report
Coherus BioSciences | 8-K: Current report
Coherus BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Temasek Holdings (Private) Limited(5.4%),Fullerton Management Pte Ltd(5.4%), etc.
Coherus BioSciences | 8-K/A: Current report (Amendment)
Coherus BioSciences | DEFA14A: Others
Coherus BioSciences | 10-Q: Quarterly report
Coherus BioSciences | 8-K: Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
Coherus BioSciences | 8-K: Current report
No Data